What is ACLARION INC's earnings per share (EPS)?

ACLARION INC (ACONW) reported diluted earnings per share of -$13.61 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ACLARION INC (ACONW) Financials

ACONW

FY2025 annual

Revenue $76K +65.6% YoY

Net Income -$7.2M -3.4% YoY

EPS (Diluted) -$13.61 YoY not available

Free Cash Flow -$7.2M -36.2% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 6, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ACONW SEC filings page.

ACLARION INC (ACONW) reported $76K in revenue for fiscal year 2025, up 65.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ACONW FY2025 2026-08-29

Financing rebuilt the balance sheet, but the operating model still converts modest revenue into substantial cash consumption.

The 2025 gross-margin swing from -85.2% to 9.0% still left the company with a $7.1M operating loss, because the improved gross economics did not absorb the broader operating cost base. Operating cash flow of -$7.2M nearly matched net loss of -$7.2M, indicating that the reported loss was largely a cash event rather than mainly a noncash accounting effect.

The business remains development-stage in financial scale: FY2025 R&D spending of $1.0M exceeded revenue of $75.7K by a wide margin. That imbalance means reported revenue is not yet carrying the investment required to operate the business.

A $18.9M financing inflow was large relative to FY2025 current liabilities of $837K, indicating that the balance-sheet improvement came primarily through financing rather than operating earnings. Current ratio rose from 0.7x in FY2024 to 14.8x in FY2025, while free cash flow remained negative and capital expenditures were only $22K; the cash use is therefore chiefly operational, not a heavy physical-asset build.

Financial Health Signals

Financial health score not available

ACLARION INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/8

ACLARION INC passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

ACLARION INC reported a net loss of $7.2M while operations used $7.2M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$25K

YoY+30.5%

QoQ+19.2%

5Y CAGR-0.3%

ACLARION INC generated $25K in revenue in Q2 2026. This represents an increase of 30.5% from the same quarter a year earlier. Against the prior quarter it is up 19.2%.

EBITDA

-$2.8M

YoY-68.7%

QoQ+3.0%

ACLARION INC's EBITDA was -$2.8M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 68.7% from the same quarter a year earlier. Against the prior quarter it is up 3.0%.

Net Income

-$2.7M

YoY-71.6%

QoQ+3.7%

ACLARION INC reported -$2.7M in net income in Q2 2026. This represents a decrease of 71.6% from the same quarter a year earlier. Against the prior quarter it is up 3.7%.

EPS (Diluted)

-$1.12

QoQ+16.4%

ACLARION INC earned -$1.12 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 16.4%.

Cash & Balance Sheet

Cash & Debt

$16.3M

YoY+27.0%

QoQ-14.3%

5Y CAGR+50.8%

ACLARION INC held $16.3M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

QoQ+17.1%

ACLARION INC had 3M shares outstanding in Q2 2026. Against the prior quarter it is up 17.1%.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

32.9%

YoY+6.3pp

QoQ+15.2pp

5Y CAGR+12.2pp

ACLARION INC's gross margin was 32.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 6.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.2 percentage points.

Return on Equity

-16.2%

YoY-4.9pp

QoQ-1.6pp

ACLARION INC's ROE was -16.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 4.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.6 percentage points.

Operating Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending

$297K

YoY+9.8%

QoQ-5.8%

5Y CAGR+12.8%

ACLARION INC invested $297K in research and development in Q2 2026. This represents an increase of 9.8% from the same quarter a year earlier. Against the prior quarter it is down 5.8%.

Share Buybacks

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

ACONW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ACONW quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K
Revenue	$84K	$76K+65.6%	$46K-39.4%	$75K+24.8%	$60K+0.3%	$60K
Cost of Revenue	$66K	$69K-18.6%	$85K+11.8%	$76K+16.0%	$65K-5.6%	$69K
Gross Profit	$18K	$7K+117.5%	-$39K-11916.7%	-$324+93.3%	-$5K+45.4%	-$9K
R&D Expenses	$1.2M	$1.0M+16.3%	$889K+1.8%	$873K-18.2%	$1.1M+35.6%	$788K
SG&A Expenses	$5.5M	$4.1M+14.3%	$3.6M+11.2%	$3.2M-18.7%	$4.0M+118.6%	$1.8M
Operating Income	-$9.7M	-$7.1M-27.9%	-$5.5M-13.1%	-$4.9M+12.3%	-$5.6M-88.3%	-$3.0M
EBITDA	N/A	-$6.8M-28.3%	-$5.3M-12.9%	-$4.7M+13.0%	-$5.4M-95.8%	-$2.8M
Interest Expense	N/A	N/A	$64K-42.0%	$111K-92.7%	$1.5M+217.4%	$475K
Income Tax	$0	$0	$0	$0	$0	$0
Net Income	-$9.2M	-$7.2M-3.4%	-$7.0M-42.4%	-$4.9M+30.5%	-$7.1M-42.8%	-$5.0M
EPS (Basic)	N/A	-$13.61+99.8%	-$7478.90+90.6%	-$79782.00-406743.4%	-$19.61-198.0%	-$6.58
EPS (Diluted)	—	-$13.61	-$7478.90	-$79782.00	-$19.61	-$6.58
Diluted Shares (Avg)	N/A	532,036	943	62	381,598	905,685

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$25K+30.5%	$21K+11.3%	$18K+80.6%	$19K+31.5%	$19K+76.1%	$19K+87.8%	$10K-25.8%	$14K-24.4%
Cost of Revenue	$17K+19.3%	$17K-25.9%	$17K-18.8%	$15K-31.8%	$14K-39.1%	$23K+20.6%	$21K+5.9%	$21K+9.1%
Gross Profit	$8K+61.4%	$4K+183.6%	$2K+117.3%	$4K+163.3%	$5K+141.7%	-$4K+52.1%	-$10K-83.7%	-$7K-1304.7%
R&D Expenses	$297K+9.8%	$315K+59.1%	$263K+4.5%	$302K+54.3%	$270K+33.8%	$198K-17.1%	$252K+14.1%	$196K-1.2%
SG&A Expenses	$1.7M+53.8%	$1.8M+79.0%	$1.1M-8.0%	$901K+4.7%	$1.1M+62.0%	$987K+16.6%	$1.2M+67.3%	$860K+11.7%
Operating Income	-$2.9M-67.0%	-$3.0M-100.2%	-$2.0M-10.3%	-$1.8M-41.3%	-$1.7M-52.9%	-$1.5M-17.0%	-$1.8M-60.4%	-$1.3M-11.5%
EBITDA	-$2.8M-68.7%	-$2.9M-103.7%	-$1.9M-10.2%	-$1.8M-42.3%	-$1.7M-54.4%	-$1.4M-16.8%	-$1.8M-61.7%	-$1.2M-11.1%
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	-$2.7M-71.6%	-$2.9M-40.1%	-$1.9M+5.0%	-$1.7M-24.9%	-$1.6M-29.3%	-$2.0M+15.1%	-$2.0M-57.2%	-$1.4M-36.9%
EPS (Basic)	-$1.12+59.3%	-$1.34+85.6%	-$2.01+99.9%	-$2.93+99.8%	-$2.75+99.8%	-$9.32+99.8%	-$1585.25-18817.1%	-$1321.49-70567.9%
EPS (Diluted)	-$1.12	-$1.34	-$2.01	-$2.93	-$2.75	-$9.32	-$1585.25	-$1321.49
Diluted Shares (Avg)	2M	2M	N/A	582,371	582,371	219,366	N/A	1,043

Not reported in any period shown, so not listed: Interest Expense.

ACONW Balance Sheet

ACONW quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K
Total Assets	$13.7M+543.9%	$2.1M-13.7%	$2.5M-15.6%	$2.9M+54.3%	$1.9M
Current Assets	$12.4M+1403.9%	$824K-36.1%	$1.3M-24.2%	$1.7M+132.3%	$732K
Cash & Equivalents	$12.0M+2548.6%	$454K-55.6%	$1.0M-30.7%	$1.5M+240.5%	$433K
Short-Term Investments	$0	$0	$0	$0	$0
Accounts Receivable	$30K+62.0%	$18K+38.1%	$13K-28.5%	$19K+195.7%	$6K
Long-Term Investments	$0	$0	$0	$0	$0
Total Liabilities	$837K-27.4%	$1.2M-63.8%	$3.2M+362.9%	$689K-95.3%	$14.7M
Current Liabilities	$837K-27.4%	$1.2M-63.8%	$3.2M+362.9%	$689K-91.0%	$7.6M
Non-Current Liabilities	$0	$0	$0	$0-100.0%	$7.1M
Total Equity	$12.8M+1223.1%	$970K+233.3%	-$728K-132.7%	$2.2M+117.3%	-$12.8M
Retained Earnings	-$58.5M-14.1%	-$51.3M-15.8%	-$44.3M-12.5%	-$39.4M-23.5%	-$31.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$18.0M+22.3%	$20.6M+25.2%	$13.7M+543.9%	$13.2M+314.1%	$14.8M+377.7%	$16.5M+342.1%	$2.1M-13.7%	$3.2M+106.6%
Current Assets	$16.8M+24.9%	$19.4M+27.8%	$12.4M+1403.9%	$11.9M+527.5%	$13.4M+625.8%	$15.2M+497.1%	$824K-36.1%	$1.9M+419.9%
Cash & Equivalents	$16.3M+27.0%	$19.0M+28.8%	$12.0M+2548.6%	$11.3M+764.4%	$12.8M+993.7%	$14.8M+591.6%	$454K-55.6%	$1.3M+665.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$28K+34.7%	$41K+111.7%	$30K+62.0%	$32K+88.9%	$21K+6.1%	$19K+11.4%	$18K+38.1%	$17K-20.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$1.0M+83.7%	$986K+41.1%	$837K-27.4%	$700K+3.2%	$564K-61.0%	$699K-42.8%	$1.2M-63.8%	$678K-71.4%
Current Liabilities	$1.0M+83.7%	$986K+41.1%	$837K-27.4%	$700K+3.2%	$564K-61.0%	$699K-42.8%	$1.2M-63.8%	$678K-71.4%
Non-Current Liabilities	$0	$0	$0	$0	$0	$0	$0	$0
Total Equity	$17.0M+19.8%	$19.7M+24.5%	$12.8M+1223.1%	$12.5M+398.1%	$14.2M+764.1%	$15.8M+529.9%	$970K+233.3%	$2.5M+403.1%
Retained Earnings	-$64.1M-16.8%	-$61.3M-15.1%	-$58.5M-14.1%	-$56.6M-14.9%	-$54.9M-14.6%	-$53.3M-14.2%	-$51.3M-15.8%	-$49.3M-14.5%

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

ACONW Cash Flow Statement

ACONW quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K
Operating Cash Flow	-$8.1M	-$7.2M-35.9%	-$5.3M-44.5%	-$3.6M+26.3%	-$4.9M-106.2%	-$2.4M
Depreciation & Amortization	N/A	$227K+17.7%	$193K+18.7%	$163K+13.3%	$144K-22.9%	$186K
Stock-Based Compensation	N/A	$105K-63.3%	$287K-37.0%	$456K-61.6%	$1.2M+568.6%	$177K
Capital Expenditures	N/A	$22K+320.9%	$5K	$0	N/A	N/A
Free Cash Flow	N/A	-$7.2M-36.2%	-$5.3M-44.7%	-$3.6M	N/A	N/A
Investing Cash Flow	-$174K	-$204K+36.7%	-$322K-169.4%	-$120K+42.5%	-$208K-103.8%	-$102K
Financing Cash Flow	$11.7M	$18.9M+276.9%	$5.0M+51.6%	$3.3M-46.4%	$6.2M+110.5%	$2.9M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	$60K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	-$2.7M-42.4%	-$2.6M-5.2%	-$1.6M-76.3%	-$1.2M-9.9%	-$1.9M-76.9%	-$2.5M-12.2%	-$923K-25.8%	-$1.1M-10.8%
Depreciation & Amortization	$62K+14.8%	$61K+10.4%	$61K+17.4%	$58K+16.7%	$54K+17.8%	$55K+22.3%	$52K+25.0%	$50K+21.8%
Stock-Based Compensation	$102K+260.1%	$5K-91.6%	N/A	$17K-77.6%	$28K-59.7%	$56K-34.9%	N/A	$75K-45.6%
Capital Expenditures	N/A	N/A	$14K+168.3%	$7K	N/A	N/A	$5K	$0
Free Cash Flow	N/A	N/A	-$1.6M-76.9%	-$1.2M-10.6%	N/A	N/A	-$928K	-$1.1M
Investing Cash Flow	-$43K+1.9%	-$49K+37.0%	-$41K+31.7%	-$40K+61.3%	-$44K+53.1%	-$78K-23.0%	-$61K-79.0%	-$104K-699.6%
Financing Cash Flow	-$19K-1928300.0%	$9.7M-42.7%	$2.3M+1772.6%	-$284K-121.9%	-$1-100.0%	$16.9M+394.6%	$125K-92.3%	$1.3M+148.6%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ACONW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ACONW quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K
Gross Margin	9.0%+94.2pp	-85.2%-84.7pp	-0.4%+7.6pp	-8.0%+6.7pp	-14.7%
Operating Margin	-9312.6%	-12057.2%	-6466.5%	-9201.2%	-4897.9%
Net Margin	-9551.9%	-15293.8%	-6513.4%	-11694.5%	-8210.5%
Return on Equity	-56.4%+664.5pp	-720.9%	N/A	-317.6%	N/A
Return on Assets	-52.9%+276.4pp	-329.3%-129.6pp	-199.7%+42.8pp	-242.5%+19.5pp	-262.0%
Current Ratio	14.81+14.1x	0.71+0.3x	0.40-2.1x	2.47+2.4x	0.10
Debt-to-Equity	0.07-1.1x	1.19	N/A	0.31	N/A
Asset Turnover	0.010.0x	0.020.0x	0.030.0x	0.020.0x	0.03
FCF Margin	-9488.6%	-11540.4%	-4836.5%	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	32.9%+6.3pp	17.7%+41.4pp	9.7%	23.2%+71.2pp	26.6%	-23.6%+68.9pp	-100.9%	-48.1%-45.5pp
Operating Margin	-11503.2%	-14129.3%	-10785.8%	-9666.2%	-8988.6%	-7856.0%	-17652.7%	-8995.3%
Net Margin	-10899.5%	-13498.5%	-10223.7%	-9008.0%	-8285.9%	-10728.4%	-19444.6%	-9482.7%
Return on Equity	-16.2%-4.9pp	-14.5%-1.6pp	-14.7%+190.4pp	-13.7%+40.8pp	-11.3%+64.1pp	-12.9%+82.8pp	-205.1%	-54.4%
Return on Assets	-15.2%-4.4pp	-13.8%-1.5pp	-13.8%+79.9pp	-12.9%+29.9pp	-10.8%+29.2pp	-12.4%+52.0pp	-93.7%-42.3pp	-42.9%+21.8pp
Current Ratio	16.20-7.6x	19.65-2.0x	14.81+14.1x	17.01+14.2x	23.81+22.5x	21.68+19.6x	0.71+0.3x	2.80+2.6x
Debt-to-Equity	0.060.0x	0.050.0x	0.07-1.1x	0.06-0.2x	0.04-0.8x	0.04-0.4x	1.19	0.27
Asset Turnover	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x
FCF Margin	N/A	N/A	-8881.7%	-6164.6%	N/A	N/A	-9069.4%	-7327.3%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
ACLARION INC ACONW	FY2025	$76K	-$7.2M	N/A	N/A	—
CARECLOUD INC CCLDO	FY2025	$120.5M	$11K	0.0%	N/A	46/100
Lifemd, Inc. LFMDP	FY2025	$194.1M	-$11.2M	-5.8%	N/A	41/100
Aclarion Inc ACON	FY2025	$76K	-$7.2M	N/A	$6.8M	—
OneMedNet ONMDW	FY2025	$1.4M	-$2.8M	N/A	N/A	17/100
Heartbeam Inc BEAT	FY2025	N/A	-$21.0M	N/A	$26.3M	—

Where ACLARION INC Ranks

Frequently Asked Questions

What is ACLARION INC's annual revenue?

ACLARION INC (ACONW) reported $76K in total revenue for fiscal year 2025. This represents a 65.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ACLARION INC's revenue growing?

ACLARION INC (ACONW) revenue grew by 65.6% year-over-year, from $46K to $76K in fiscal year 2025.

Is ACLARION INC profitable?

No, ACLARION INC (ACONW) reported a net income of -$7.2M in fiscal year 2025.

What is ACLARION INC's EBITDA?

ACLARION INC (ACONW) had EBITDA of -$6.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is ACLARION INC's gross margin?

ACLARION INC (ACONW) had a gross margin of 9.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is ACLARION INC's return on equity (ROE)?

ACLARION INC (ACONW) has a return on equity of -56.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is ACLARION INC's free cash flow?

ACLARION INC (ACONW) recorded an outflow of $7.2M in free cash flow during fiscal year 2025. This represents a -36.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is ACLARION INC's operating cash flow?

ACLARION INC (ACONW) recorded an outflow of $7.2M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are ACLARION INC's total assets?

ACLARION INC (ACONW) had $13.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are ACLARION INC's capital expenditures?

ACLARION INC (ACONW) invested $22K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does ACLARION INC spend on research and development?

ACLARION INC (ACONW) invested $1.0M in research and development during fiscal year 2025.

How many shares does ACLARION INC have outstanding?

ACLARION INC (ACONW) had 2M shares outstanding as of fiscal year 2025.

What is ACLARION INC's current ratio?

ACLARION INC (ACONW) had a current ratio of 14.81 as of fiscal year 2025, which is generally considered healthy.

What is ACLARION INC's debt-to-equity ratio?

ACLARION INC (ACONW) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is ACLARION INC's return on assets (ROA)?

ACLARION INC (ACONW) had a return on assets of -52.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is ACLARION INC's Piotroski F-Score?

ACLARION INC (ACONW) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are ACLARION INC's earnings high quality?

ACLARION INC (ACONW) reported a net loss of $7.2M while operations used $7.2M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.